Building Your Care Team

There are no HCS clinics. There is no published multidisciplinary care guideline. What exists is a pattern from the literature: the patients who do best are the ones who assemble a coordinated team across multiple specialties and make sure those specialists actually talk to each other.

Endocrinologist

Your quarterback for bone health. Manages bisphosphonates, denosumab, or romosozumab. Orders and interprets DEXA scans. Monitors bone turnover markers (CTX, P1NP). In Alberta, for me anyway, I have a Rheumatologist who manages these things for me.

Neurosurgeon / Neurologist

Basilar invagination and Chiari malformation occur in roughly half of HCS patients and can be life-threatening. Needs to be monitoring with periodic imaging even if you're asymptomatic.

Cardiologist

Congenital heart defects and valve disease are documented in HCS. One patient required mitral valve replacement at age 14 and a pacemaker at 18. Echocardiographic monitoring may be essential.

Nephrologist

Polycystic kidney disease appears in an estimated 10% of HCS patients and has progressed to end-stage renal failure in documented cases. Renal ultrasound at diagnosis and periodic monitoring are critical.

Dental Specialist

HCS causes progressive alveolar bone atrophy, severe periodontal disease, and premature tooth loss. Avoid invasive procedures where possible — especially if you're on bisphosphonates.

Audiologist

Hearing loss — both sensorineural and conductive — is a recognized feature of HCS. Annual audiometry catches changes early enough for hearing aid fitting or other intervention.

Respirologist

Thoracic deformities cause restrictive lung disease. Basilar invagination can cause central respiratory arrest. Vocal cord paralysis has also been documented.

Clinical Geneticist

Confirms diagnosis via NOTCH2 exon 34 sequencing. Essential for family planning discussions and coordinating preimplantation genetic testing (PGT-M) if desired.

No single specialist can manage HCS alone. Print your medication list and bring it to every appointment. It sounds basic. It's the most protective thing you can do.

Monitoring Schedule

There is no published surveillance protocol for HCS. The schedule below is derived from the clinical literature and case report recommendations.

Educational illustration comparing a normal femur with an osteoporotic femur. On the left, dense trabecular bone with a tightly woven internal matrix; on the right, sparse and thinned trabeculae. Two magnified circular insets show the same contrast between dense and degraded bone architecture.
What the DEXA scan is measuring. Normal trabecular bone (left) versus osteoporotic bone (right) — the thinning and loss of the internal meshwork is exactly what HCS drives and what the monitoring schedule below is designed to catch. Educational illustration.

DEXA Bone Density Scan

Quantifies osteoporosis severity, tracks treatment response

Annual

Bone Turnover Markers (CTX, P1NP)

Tracks osteoclast activity and treatment response

Every 6 months

Hand & Foot X-rays

Documents acro-osteolysis progression

Annual

Skull Base CT or MRI

Screens for basilar invagination and Chiari malformation

Every 1–2 years

Spine X-ray Series

Compression fractures, kyphosis, scoliosis, cervical instability

Annual

Echocardiogram

Valvular disease, congenital defects

Annual

Renal Ultrasound + Function Panel

Polycystic kidneys in ~10% of patients

Annual

Audiometry

Progressive sensorineural and/or conductive hearing loss

Annual

Pulmonary Function Tests

Restrictive lung disease from thoracic deformities

Baseline + as indicated

Dental Exam with Panoramic X-ray

Alveolar bone atrophy, periodontal disease, root resorption

Every 6 months

Keep a binder. With fewer than 100 known cases, most specialists you see will be encountering HCS for the first time.

Emergency Red Flags

Some HCS complications are slowly progressive. Others aren't. These are the signs that mean you need emergency evaluation.

Two lateral cervical spine X-rays displayed side by side on a clinical monitor, showing distorted vertebral architecture and instability typical of an HCS patient with basilar invagination and cervical compromise.
Cervical spine instability is not theoretical. These are my own cervical X-rays. Basilar invagination, compression fractures, and upper-cervical instability can present without dramatic warning — the red flags below are the signs that mean you go to emergency. Imaging courtesy of Thomas Cheesman.
  • Severe sudden headache with neck stiffness, vomiting, or vision changes — may indicate hydrocephalus from basilar invagination
  • New weakness, numbness, or coordination loss in arms or legs — spinal cord compression
  • Difficulty swallowing or breathing that worsens rapidly — upper airway obstruction or brainstem compression
  • Sleep apnea that suddenly worsens — central respiratory arrest from basilar invagination is a documented cause of death
  • Chest pain, palpitations, or fainting — cardiac valve disease can worsen unpredictably
  • Blood in urine or severe flank pain — may signal renal cyst complication
  • New seizures — documented in HCS patients with neurological involvement
  • Sudden severe back pain with height loss — vertebral compression fracture

Surgical & Anesthesia Safety

HCS is classified in anesthesia literature as one of the most difficult airway-related syndromes. Print this section. Bring it.

Airway Challenges — Why Intubation Is Dangerous

Micrognathia, abnormal dentition, short neck, and cervical spine deformities combine to create a textbook difficult airway. Published case reports recommend video laryngoscopy or fibreoptic intubation. Cervical spine instability means neck extension during intubation is dangerous.

Bleeding Risk & Coagulation

NOTCH2 mutations are associated with bleeding risks. The anesthesia literature recommends preoperative coagulation profile assessment and ensuring adequate blood products are available.

Positioning & Fracture Prevention

Severe osteoporosis and joint laxity mean that positioning during surgery can itself cause fractures. Pressure points need extra padding. The surgical team needs to handle positioning gently.

Spinal Surgery — Why HCS Makes It Harder

Spinal surgery in HCS is documented as exceptionally challenging. Distorted anatomy, reduced bone strength making screw fixation unreliable, and osteolysis causing fusion failure are all documented complications.

Respiratory Considerations During Surgery

HCS patients may have severe restrictive lung disease from thoracic deformities. Pulmonary function testing before any planned surgery gives the anesthesia team the data they need.

Share these recommendations with your surgical team before the procedure, not the morning of.

Dental Management — The Bisphosphonate Paradox

HCS attacks your teeth from below. The alveolar bone progressively atrophies, causing severe periodontal disease and premature tooth loss.

3D CT reconstruction of a human upper and lower jaw in bronze tones, with all teeth visible in occlusion. The reconstruction shows the alveolar bone architecture supporting the dentition in a patient with Hajdu-Cheney Syndrome.
What alveolar atrophy looks like from the inside. 3D CT reconstruction of my own upper and lower jaw. Progressive loss of the bone that holds the teeth in place is one of the defining clinical features of HCS — and the reason the guidance below leans so hard on preservation over extraction. Imaging courtesy of Thomas Cheesman.

Here's the paradox: bisphosphonates — the most commonly prescribed medications for HCS osteoporosis — carry a known risk of osteonecrosis of the jaw (ONJ).

What the Literature Recommends

Preserve — Don't Extract

The literature explicitly recommends avoiding invasive dental procedures where possible. Conservative restorations are preferred over extractions.

Bisphosphonate-Jaw Risk Coordination

If you're on bisphosphonates, your dentist must know before any invasive procedure. Timing relative to bisphosphonate dosing matters.

Frequent Monitoring Protocol

Dental exams every six months with panoramic X-rays. Aggressive preventive care — professional cleanings, fluoride, meticulous home hygiene.

Beyond Bones — Heart, Kidneys & Lungs

NOTCH2 signaling is involved in the development of the heart, kidneys, and other organs. The extraskeletal complications can be just as serious.

Cardiovascular Complications

Documented cardiac findings include patent ductus arteriosus, septal defects, and valve abnormalities. Romosozumab (Evenity) carries a black-box cardiovascular warning — if you have any cardiac involvement, this needs careful discussion.

Kidney Involvement — The SFPKS Connection

What used to be called serpentine fibula-polycystic kidney syndrome (SFPKS) is now recognized as the same condition as HCS. Polycystic kidneys in approximately 10% of patients, with at least one case progressing to end-stage renal failure by age 14.

Respiratory System

Three respiratory threats: thoracic deformities creating restrictive lung disease, recurrent respiratory infections, and basilar invagination compressing the brainstem causing central respiratory arrest.

Hearing & Voice Changes

A deep, gravelly voice is one of the recognized features of HCS. Hearing loss is more consequential. Both sensorineural and conductive loss have been documented, and in some cases the loss is progressive.

Annual audiometry is the only way to catch it before it significantly impacts daily life — especially in children, where undetected hearing loss affects speech and language development.

How HCS Changes Over Time

HCS is present from birth, but it doesn't look the same at every age. Different systems become affected at different life stages, and the condition generally worsens over time.

Birth – 2 yrsInfancy
Congenital features present at birth: cleft palate, congenital heart defects, open cranial sutures, wormian bones. Most children have normal mental development.
2 – 12 yrsChildhood
Skeletal manifestations become clinically apparent: short stature, joint hypermobility, early fractures, acro-osteolysis. Abnormal dental eruption and early tooth loss start. Facial features become more recognizable.
12 – 25 yrsAdolescence
Osteoporosis accelerates: vertebral compression fractures, progressive height loss, worsening kyphosis. Many patients are first diagnosed during this period. This is when bone treatment becomes urgent.
25+ yrsAdulthood
Progressive complications accumulate: continued bone density loss, ongoing acro-osteolysis, progressive hearing loss, worsening dental disease. Neurological complications may progress.

The age-dependent pattern is why early diagnosis matters — not because we have a cure, but because starting treatment earlier gives you the best chance of staying ahead of the progression.

Family Planning & Inheritance

HCS follows autosomal dominant inheritance.

50%Chance per
pregnancy

If one parent has HCS, each pregnancy carries a 50% chance of the child inheriting the NOTCH2 variant. This applies equally to sons and daughters.

However, many cases of HCS are de novo — meaning the mutation occurred spontaneously. If your child has HCS but neither parent does, the recurrence risk for future siblings is very low.

There is nothing a parent did to cause the mutation. This is not caused by anything during pregnancy.

Two-column diagram comparing wild-type NOTCH2 (left, blue background) with Hajdu-Cheney mutant NOTCH2 (right, peach background). Wild-type NOTCH2 has an intact PEST domain and is recognised and ubiquitinated by the SCF-FBW7 complex (E2, RBX1, Cullin1, Skp1, FBW7), routed to proteasomal degradation, producing physiological osteoclast activity and normal bone resorption. The Hajdu-Cheney mutant has a truncated PEST domain, escapes SCF-FBW7 recognition, accumulates as protein, and drives pathogenic osteoclast activity with excessive bone resorption; DAPT, a gamma-secretase inhibitor, is shown as a candidate therapeutic at the top of the mutant pathway.
What the NOTCH2 variant actually does. Normal NOTCH2 is tagged for destruction by the SCFFBW7 complex after it signals. The Hajdu-Cheney mutation truncates the PEST domain at the end of NOTCH2, so the protein evades that destruction step, accumulates, and drives excessive osteoclast activity — the cellular engine of the bone loss, acro-osteolysis, and dental atrophy that dominate the clinical picture. Gamma-secretase inhibitors like DAPT are being explored preclinically as a way to block the upstream signal. Published molecular diagram — original attribution pending. If you know the source, please let us know.

Preimplantation Genetic Testing (PGT-M)

Families who wish to have children without HCS can use PGT-M. This involves creating embryos through IVF, testing each for the specific NOTCH2 variant, and transferring only unaffected embryos.

A genetic counselor is your best resource here. Ask your geneticist for a referral — or contact your provincial/state genetics program directly.

Your Story Matters

You know more about HCS than most doctors you'll meet. That's the reality of living with an ultra-rare condition — the knowledge you carry about your body, your progression, your responses to treatment is data that doesn't exist anywhere else. Share it. It matters.

Send Your Feedback

Your comments, corrections, and stories help keep this resource accurate and useful. All fields except your message are optional.

Community Voices

Stories and insights from the HCS community will appear here as they are submitted and reviewed. Be the first to share yours.

Last reviewed: